CTMX icon

CytomX Therapeutics
CTMX

Overview Fund Activity

90 hedge funds and large institutions have $343M invested in CytomX Therapeutics in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 42 increasing their positions, 14 reducing their positions, and 15 closing their positions.

Holders
90
Holders Change
+4
Holders Change %
+4.65%
% of All Funds
2.25%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
19
Increased
42
Reduced
14
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
1
BlackRock
New York
$28.1M
2
NI
2
Numeric Investors
Massachusetts
$9.73M
3
BI
3
BVF Inc
California
$31.4M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$6.37M
5
State Street
5
State Street
Massachusetts
$6.91M

Top Sellers

1
DM
1
Deerfield Management
New York
$11.7M
2
PA
2
Perceptive Advisors
New York
$21.6M
3
MBT
3
Montecito Bank & Trust
California
$443K
4
PAG
4
Private Advisor Group
New Jersey
$1.64M
5
PI
5
Putnam Investments
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
DTL
101
Dynamic Technology Lab
Singapore
– -$206K -11,956 Closed
ARTA
102
A.R.T. Advisors
New York
– -$179K -10,400 Closed
HIM
103
Hillsdale Investment Management
Ontario, Canada
– -$159K -9,200 Closed
TRCT
104
Tower Research Capital (TRC)
New York
– -$5K -289 Closed
FMA
105
FNY Managed Accounts
New York
– -$2K -161 Closed
MIM
106
Monashee Investment Management
Massachusetts
– -$798K – –
1 2 3 4
5